ID: MRFR/MED/1766-CR | 47 Pages | Author: Rahul Gotadki | February 2021
1 Introduction
1.1.1 Prevalence of the Uterine Fibroids in U.S. 8
2 Scope of Study
2.1 Research Objective 10
2.2 Assumptions & Limitations 10
2.2.1 Assumptions 10
2.2.2 Limitations 10
2.3 Market Structure 11
3 Research Methodology
3.1 Primary Research 13
3.2 Secondary Research 13
4 U.S. Uterine Fibroid Market
4.1 Introduction 15
4.2 U.S. Uterine Fibroid Market, By Type 17
4.3 U.S. Uterine Fibroid Market, By Diagnosis 19
4.4 U.S. Uterine Fibroid Market, By Treatment 21
5 Company Profile
5.1 AstraZeneca 29
5.1.1 Company Overview 29
5.1.2 Product overview 29
5.1.3 Financial Overview 30
5.1.4 Key Development 31
5.1.5 SWOT Analysis 32
5.2 Cook Medical Inc. 33
5.2.1 Overview 33
5.2.2 Product Overview 33
5.2.3 Financials 33
5.2.4 Key Developments 33
5.2.5 SWOT Analysis 34
5.3 Boston Scientific Corporation 35
5.3.1 Company Overview 35
5.3.2 Product/Business Segment Overview 35
5.3.3 Financial Overview 35
5.3.4 Key Development 36
5.3.1 SWOT Analysis 37
5.4 GE Healthcare 38
5.4.1 Company Overview 38
5.4.2 Product/Business Segment Overview 38
5.4.3 Financial Overview 38
5.4.4 Key Development 40
5.4.5 SWOT Analysis 40
5.5 AbbVie Inc. 41
5.5.1 Company Overview 41
5.5.2 Product/Business Segment Overview 41
5.5.3 Financial Overview 41
5.5.4 Key Development 43
5.5.5 SWOT Analysis 43
5.6 Hologic, Inc. 44
5.6.1 Company Overview 44
5.6.2 Product/Business Segment Overview 44
5.6.3 Financial Overview 44
5.6.4 Key Development 46
5.6.5 SWOT Analysis 46
6 List of Tables
TABLE 1 U.S. UTERINE FIBROID MARKET, BY TYPE, 2020-2027 (USD MILLION) 18
TABLE 2 U.S. UTERINE FIBROID MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 20
TABLE 3 U.S. UTERINE FIBROID MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 23
TABLE 4 U.S. UTERINE FIBROID MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 24
TABLE 5 PIPELINE PRODUCTS FOR UTERINE FIBROIDS 27
TABLE 6 ASTRAZENECA: KEY DEVELOPMENT 31
TABLE 7 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENT 36
TABLE 8 GE HEALTHCARE: KEY DEVELOPMENT 40
TABLE 9 ABBVIE INC.: KEY DEVELOPMENT 43
TABLE 10 HOLOGIC INC.: KEY DEVELOPMENT 46
7 List of Figures
FIGURE 1 COMPARISON BETWEEN DIAGNOSIS & TREATMENT MARKET, 2020-2027 (USD MILLION) 9
FIGURE 2 U.S. UTERINE FIBROID MARKET: MARKET STRUCTURE 11
FIGURE 3 RESEARCH PROCESS 12
FIGURE 4 U.S. UTERINE FIBROID MARKET, BY TYPE, 2023-2032 (USD MILLION) 18
FIGURE 5 U.S. UTERINE FIBROID MARKET, BY DIAGNOSIS, 2023-2032 (USD MILLION) 20
FIGURE 6 TREATMENTS FOR UTERINE FIBROIDS 22
FIGURE 7 U.S. UTERINE FIBROID MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 23
FIGURE 8 U.S. UTERINE FIBROID MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 24
FIGURE 9 PHARMACOTHERAPY TREATMENT FORECAST, 2020-2027 26
FIGURE 10 ASTRAZENECA: RECENT FINANCIAL 30
FIGURE 11 ASTRAZENECA: GEOGRAPHICAL MIX 30
FIGURE 12 ASTRAZENECA: OPERATING SEGMENTS 31
FIGURE 13 ASTRAZENECA: SWOT ANALYSIS 32
FIGURE 14 BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL 35
FIGURE 15 BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL 36
FIGURE 16 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 37
FIGURE 17 GE HEALTHCARE: RECENT FINANCIAL 38
FIGURE 18 GE HEALTHCARE: GEOGRAPHICAL MIX 39
FIGURE 19 GE HEALTHCARE: OPERATING SEGMENTS 39
FIGURE 20 GE HEALTHCARE: SWOT ANALYSIS 40
FIGURE 21 ABBVIE INC.: RECENT FINANCIAL 41
FIGURE 22 ABBVIE INC.: GEOGRAPHICAL MIX 42
FIGURE 23 ABBVIE INC: OPERATING SEGMENTS 42
FIGURE 24 ABBVIE INC.: SWOT ANALYSIS 43
FIGURE 25 HOLOGIC INC.: RECENT FINANCIAL 44
FIGURE 26 HOLOGIC INC: GEOGRAPHICAL MIX 45
FIGURE 27 HOLOGIC INC: OPERATING SEGMENTS 45
FIGURE 28 HOLOGIC INC.: SWOT ANALYSIS 46
Uterine Fibroid Market Segmentation
Uterine Fibroid Type Outlook (USD Billion, 2018-2032)
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Uterine Fibroid Diagnosis Outlook (USD Billion, 2018-2032)
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Uterine Fibroid Treatment Outlook (USD Billion, 2018-2032)
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Uterine Fibroid Regional Outlook (USD Billion, 2018-2032)
North America Outlook (USD Billion, 2018-2032)
North America Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
North America Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
North America Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
US Outlook (USD Billion, 2018-2032)
US Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
US Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
US Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
CANADA Outlook (USD Billion, 2018-2032)
CANADA Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
CANADA Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
CANADA Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Europe Outlook (USD Billion, 2018-2032)
Europe Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Europe Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Europe Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Germany Outlook (USD Billion, 2018-2032)
Germany Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Germany Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Germany Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
France Outlook (USD Billion, 2018-2032)
France Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
France Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
France Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
UK Outlook (USD Billion, 2018-2032)
UK Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
UK Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
UK Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
ITALY Outlook (USD Billion, 2018-2032)
ITALY Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
ITALY Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
ITALY Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
SPAIN Outlook (USD Billion, 2018-2032)
Spain Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Spain Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Spain Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Rest Of Europe Outlook (USD Billion, 2018-2032)
Rest Of Europe Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
REST OF EUROPE Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Rest Of Europe Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Asia-Pacific Outlook (USD Billion, 2018-2032)
Asia-Pacific Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Asia-Pacific Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Asia-Pacific Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
China Outlook (USD Billion, 2018-2032)
China Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
China Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
China Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Japan Outlook (USD Billion, 2018-2032)
Japan Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Japan Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Japan Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
India Outlook (USD Billion, 2018-2032)
India Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
India Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
India Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Australia Outlook (USD Billion, 2018-2032)
Australia Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Australia Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Australia Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
Rest of Asia-Pacific Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Rest of Asia-Pacific Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Rest of Asia-Pacific Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Rest of the World Outlook (USD Billion, 2018-2032)
Rest of the World Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Rest of the World Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Rest of the World Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Middle East Outlook (USD Billion, 2018-2032)
Middle East Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Middle East Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Middle East Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Africa Outlook (USD Billion, 2018-2032)
Africa Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Africa Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Africa Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy
Latin America Outlook (USD Billion, 2018-2032)
Latin America Uterine Fibroid by Type
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Others
Latin America Uterine Fibroid by Diagnosis
Medical Resonance Imaging (MRI) Scanners
Computed Tomography (CT)
Ultrasounds
Others
Latin America Uterine Fibroid by Treatment
Uterine Fibroid Embolization
Magnetic Resonance Guided Focused Ultrasound
Myolysis
Endometrial Ablation
Hysterectomy
Myomectomy